Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication
- 1 March 2017
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 66 (3) , 485-493
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapyJournal of Antimicrobial Chemotherapy, 2012
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirinWorld Journal of Gastroenterology, 2011
- Outcome of Sustained Virological Responders With Histologically Advanced Chronic Hepatitis C†,‡,§,¶Hepatology, 2010
- Global Burden of Aflatoxin-Induced Hepatocellular Carcinoma: A Risk AssessmentEnvironmental Health Perspectives, 2010
- Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease ProgressionGastroenterology, 2010
- Liver biopsy†Hepatology, 2009
- Hepatocellular carcinoma after sustained virologic response in hepatitis C patients without cirrhosis on a pretreatment liver biopsyEuropean Journal of Gastroenterology & Hepatology, 2009
- Development of hepatocellular carcinoma in a patient 13 years after sustained virological response to interferon against chronic hepatitis C: a case reportCases Journal, 2009
- Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapyJournal of Gastroenterology and Hepatology, 2005